Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy
{{output}}
Background: Gefitinib is known as one of the agents for treating patients with both advanced lung cancer and an epidermal growth-factor receptor mutation. In the epidermal growth-factor receptor-mutant advanced non-small-cell lun... ...
